期刊文献+

扩张型心肌病患者Th17/Treg的变化及意义 被引量:9

The Change of Th17/Treg in Patients with Dilated Cardiomyopathy and Its Significance
下载PDF
导出
摘要 目的:探讨Th17/Treg的变化及其与扩张型心肌病(DCM)发生发展的关系。方法:收集急性病毒性心肌炎(AVMC)患者及DCM患者和健康体检者的外周血,ELISA法检测血清中IL-17及TGF-β1浓度;经PE-CD4、FITC-CD25及FITC-IL-17单抗染色后,双色流式细胞术检测Th17细胞及Treg细胞的比例。结果:AVMC组Th17和IL-17高于DCM组和对照组;DCM组Treg和TGF-β1低于AVMC组与对照组;AVMC组与DCM组Th17/Treg无显著差异,但均高于对照组。结论:Thl7/Treg的升高打破了免疫平衡,促进了AVMC的发病及其向DCM的发展。 Objective:To investigate the change of Thl7/Treg in peripheral blood and its relation with pathogenesis of dilated cardiomyopathy(DCM).Method:Blood was collected from patients with acute viral myo-carditis(AVMC) or DCM and healthy people. Thl7 and Treg subsets in peripheral blood were detected by bicolor flow cytometry after stained with PE-CD4,FITC-CD25 and FITC-IL-17 mAb. ELISA method was used for measuring the levels of related cytokines IL-17 and TGF-β1.Results:Both Th17 cell and the level of related cytokine IL-17 in AVMC group were higher than DCM and healthy group. The proportion of Treg cell and the level of TGF-β1 in DCM group were lower than AVMC and healthy group. Th17/Treg between AVMC group and DCM group had no significant difference but were higher than healthy group.Conclusion:The rise of Th17/Treg disrupted the balance of immunity and contributed to the onset of AVMC and the development of DCM.
出处 《微循环学杂志》 2011年第1期32-34,I0002,共4页 Chinese Journal of Microcirculation
关键词 扩张型心肌病 急性病毒性心肌炎 TH17细胞 TREG细胞 Dilated cardiomyopathy Acute viral myocarditis Th17 cells Treg cell
  • 相关文献

参考文献2

二级参考文献68

  • 1王志民,邹玉宝,宋雷,马爱群,刘唐威,谷惠敏,卢赛兰,武鹏翥,孙兆明,何国宝,张卫,张颖,沈丽,蔡玉岭,甄一松,刘延玲,惠汝太.超声心动图检查调查8080例成人肥厚型心肌病患病率[J].中华心血管病杂志,2004,32(12):1090-1094. 被引量:59
  • 2张寄南,曹克将.肥厚型心肌病诊断与治疗——美国心脏病学学会/欧洲心脏病学学会、美国心脏病协会专家共识导读[J].中华心血管病杂志,2005,33(6):491-494. 被引量:35
  • 3廖玉华,袁璟.扩张型心肌病分子免疫治疗靶点的研究进展[J].中华医学杂志,2006,86(17):1158-1160. 被引量:8
  • 4Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93(5):841-842.
  • 5Maron BJ,Towbin JA,Thiene G,et al.Contemporary definitions and classification of the cardiomyopathies:an American Heart Association Scientific Statement from the Council on Clinical Cardiology,Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.Circulation,2006,113(14):1807-1816.
  • 6Elliott PM,Mckenna WJ.Natural history of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/11502&type=A&selectedTitle=4~58.
  • 7Cooper LT.Definition and classification of the cardiomyopathies.[EB/OL][2006-8-2].http://www.utdol.com.beckerproxy.wustl.edu/applica.../6085&type=A&selectedTitle=2~5.
  • 8McKenna WJ.Genetics of hypertrophic cardiomyopathy.[EB/OL][2006-8-2].http://www.utdol.com/utd/content/topic.do?topicKey=myoperic/9673&type=A&selectedTitle=3~58.
  • 9Poliac LC,Barron ME,Maron BJ.Hypertrophic cardiomyopathy.Anesthesiology,2006,104(1):183-192.
  • 10Maron BJ,Seidman JG,Seidman CE.Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy.J Am Coll Cardiol,2004,44(11):2125-2132.

共引文献573

同被引文献133

引证文献9

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部